2022 - Research.com Microbiology in France Leader Award
2022 - Research.com Genetics and Molecular Biology in France Leader Award
2007 - Fellow of the Royal Society, United Kingdom
1941 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the European Molecular Biology Organization (EMBO)
Stewart T. Cole mainly investigates Mycobacterium tuberculosis, Microbiology, Genetics, Tuberculosis and Virology. His work carried out in the field of Mycobacterium tuberculosis brings together such families of science as Mycobacterium leprae, Mycobacterium and Biochemistry. His Microbiology study also includes fields such as
His study in Genome, Gene, Insertion sequence, Genome project and Contig are all subfields of Genetics. His Tuberculosis research is multidisciplinary, incorporating perspectives in Immunology, Drug resistance and Pharmacology. His study in Virology is interdisciplinary in nature, drawing from both Tuberculosis vaccines, rpoB, ESAT-6 and Immunogenicity.
Stewart T. Cole mostly deals with Mycobacterium tuberculosis, Microbiology, Genetics, Tuberculosis and Gene. Stewart T. Cole works in the field of Mycobacterium tuberculosis, focusing on Mycobacterium bovis in particular. His Microbiology research includes themes of Mycobacterium, Bacteria, Virology, Buruli ulcer and Virulence.
His research investigates the connection between Tuberculosis and topics such as Drug resistance that intersect with problems in Rifampicin. Gene is closely attributed to Molecular biology in his study. His Genome research incorporates themes from Mycobacterium leprae and Computational biology.
Stewart T. Cole focuses on Mycobacterium tuberculosis, Tuberculosis, Leprosy, Mycobacterium leprae and Microbiology. The Mycobacterium tuberculosis study combines topics in areas such as Biochemistry, Mutant, Gene, Drug discovery and Virulence. His Gene study is associated with Genetics.
The study incorporates disciplines such as Prodrug and Pharmacology in addition to Tuberculosis. His Mycobacterium leprae research incorporates elements of Pathogen, Genome, Whole genome sequencing, Ancient DNA and Drug resistance. His Microbiology study deals with In vivo intersecting with In vitro.
Mycobacterium tuberculosis, Microbiology, Tuberculosis, Leprosy and Biochemistry are his primary areas of study. Stewart T. Cole studies Antimycobacterial which is a part of Mycobacterium tuberculosis. His Microbiology research is multidisciplinary, incorporating elements of Secretion, SQ109, Isoniazid and Bacteria.
His research integrates issues of Combination therapy, Drug and Pharmacology in his study of Tuberculosis. As part of the same scientific family, he usually focuses on Serology, concentrating on Variable number tandem repeat and intersecting with Virology. His work deals with themes such as Evolutionary biology, Genetics, Ancient DNA and Phylogenetics, which intersect with Mycobacterium leprae.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
S. T. Cole;R. Brosch;J. Parkhill;T. Garnier.
Massive gene decay in the leprosy bacillus
S. T. Cole;K. Eiglmeier;J. Parkhill;K. D. James.
A new evolutionary scenario for the Mycobacterium tuberculosis complex
R. Brosch;S. V. Gordon;M. Marmiesse;P. Brodin.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
A Telenti;P Imboden;F Marchesi;L Matter.
The Lancet (1993)
Nucleotide sequence of the AIDS virus, LAV
Simon Wain-Hobson;Pierre Sonigo;Olivier Danos;Stewart Cole.
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Ying Zhang;Beate Heym;Bryan Allen;Douglas Young.
The complete genome sequence of Mycobacterium bovis
Thierry Garnier;Karin Eiglmeier;Jean-Christophe Camus;Nadine Medina.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla;Payam Nahid;Stewart T. Cole.
Nature Reviews Drug Discovery (2013)
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
Alexander S. Pym;Alexander S. Pym;Priscille Brodin;Roland Brosch;Michel Huerre.
Molecular Microbiology (2002)
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
Alexander S. Pym;Alexander S. Pym;Priscille Brodin;Laleh Majlessi;Roland Brosch.
Nature Medicine (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: